Moreover, mutations in KDM6A, such as H101D & P110S, N1156T and D1216N identified in ESCC patients increase its interaction capability with SND1 and confer resistance to genotoxin resistance. This evidence concerns the gene KDM6A and esophageal squamous cell carcinoma.